NCT03549338 2020-09-28Sym004 Versus Futuximab or Modotuximab in Patients With mCRCSymphogen A/SPhase 2 Terminated2 enrolled 9 charts
NCT02083653 2019-04-16Sym004 vs Standard of Care in Subjects With Metastatic Colorectal CancerSymphogen A/SPhase 2 Completed254 enrolled 21 charts